2024-21575. Chemical Analysis for Biocompatibility Assessment of Medical Devices; Draft Guidance for Industry and Food and Drug Administration Staff; Availability  

  • 21 CFR part; guidance; or FDA form Topic OMB control No.
    807, subpart E Premarket notification 0910-0120
    814, subparts A through E Premarket approval 0910-0231
    814, subpart H Humanitarian Device Exemption 0910-0332
    812 Investigational Device Exemption 0910-0078
    860, subpart D De Novo classification process 0910-0844
    “Requests for Feedback on Medical Device Submissions: The Q-Submission Program and Meetings with Food and Drug Administration Staff” Q-Submissions and Early Payor Feedback Request Programs for Medical Devices 0910-0756

Document Information

Published:
09/20/2024
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice of availability.
Document Number:
2024-21575
Dates:
Submit either electronic or written comments on the draft guidance by November 19, 2024 to ensure that the Agency considers your comment on this draft guidance before it begins work on the final version of the guidance.
Pages:
77162-77164 (3 pages)
Docket Numbers:
Docket No. FDA-2024-D-4165
PDF File:
2024-21575.pdf